Adenosine Diphosphate–Induced Platelet Aggregation Is Associated With P2Y 12 Gene Sequence Variations in Healthy Subjects
- 26 August 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (8) , 989-995
- https://doi.org/10.1161/01.cir.0000085073.69189.88
Abstract
Background— The adenosine diphosphate (ADP) receptor P2Y12 plays a pivotal role in platelet aggregation, as demonstrated by the benefit conferred by its blockade in patients with cardiovascular disease. Some studies have shown interindividual differences in ADP-induced platelet aggregation responses ex vivo, but the mechanisms underlying this variability are unknown. Methods and Results— We examined ADP-induced platelet aggregation responses in 98 healthy volunteers, and we identified 2 phenotypic groups of subjects with high and low responsiveness to 2 μmol/L ADP. This prompted us to screen the recently identified Gi-coupled ADP receptor gene P2Y12 for sequence variations. Among the 5 frequent polymorphisms thus identified, 4 were in total linkage disequilibrium, determining haplotypes H1 and H2, with respective allelic frequencies of 0.86 and 0.14. The number of H2 alleles was associated with the maximal aggregation response to ADP in the overall study population (P=0.007). Downregulation of the platele...Keywords
This publication has 19 references indexed in Scilit:
- Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart diseasePlatelets, 2002
- The P2Y12 receptor induces platelet aggregation through weak activation of the αIIbβ3 integrin – a phosphoinositide 3‐kinase‐dependent mechanismFEBS Letters, 2001
- Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugsJournal of Clinical Investigation, 2001
- ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999Journal of Biological Chemistry, 2001
- Identification of the platelet ADP receptor targeted by antithrombotic drugsNature, 2001
- The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activityBritish Journal of Haematology, 2000
- The P2Y1 receptor, necessary but not sufficient to support full ADP‐induced platelet aggregation, is not the target of the drug clopidogrelBritish Journal of Haematology, 1998
- Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphismBritish Journal of Haematology, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.Journal of Clinical Investigation, 1995